Skip to content

Study · Case report or series · n = 1 · 2019

3 results

ADDITION OF DULAGLUTIDE FOR A HIGH-DOSE INSULIN REQUIRING PATIENT WITH TYPE 2 DIABETES MELLITUS: A REMARKABLE RESPONSE.

Kazim M, Trivedi N

AACE clinical case reports1 Nov 2018Cited by 1 (Europe PMC)

PMID31967020 (opens in a new tab)PMCIDPMC6873854 (opens in a new tab)DOI10.4158/accr-2018-0192 (opens in a new tab)PepBankPUB-31967020
Read at sourcePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. 3 results from people.

  1. 01HumanCase report or seriesEfficacy outcome

    In a man with T2DM on insulin and metformin, HbA1c declined to 6.3% after dulaglutide addition.

    In plain wordsIn a man with T2DM, blood sugar improved after dulaglutide was added to insulin and metformin.

    Peptide
    Dulaglutide (Trulicity)
    Outcome
    DecreaseHbA1c
    Study

    n = 1

    Comparator
    Before dulaglutide addition
    Outcome group
    Glycemic control · Metabolic and weight
    Studied dose
    Dose not stated · A few monthsAs given in this study (human).

    Measurements

    HbA1c
    9.7%
    before dulaglutide
    HbA1c
    6.3%
    a few months after adding dulaglutide

    Source sentences

    Summary
    A few months after adding dulaglutide to his regimen, the patient's HbA1c declined to 6.3% (45 mmol/mol) despite significant reduction in daily insulin dosage to 20 units (94% decrease), which was accompanied by a 20-pound weight loss.
    3 context sentences
    Summary · context
    We present a patient with T2DM who had marked improvement in glycemic control accompanied by weight loss and a decrease in insulin requirement after adding weekly dulaglutide to U500 regular insulin.
    Summary · context
    A 56-year-old man with T2DM, class III obesity (weight 314 pounds, body mass index 46.4 kg/m2), and hyperlipidemia had uncontrolled glycemia with a hemoglobin A1c (HbA1c) of 9.7% (83 mmol/mol) despite using high-dose insulin therapy and metformin.
    Summary · context
    had uncontrolled glycemia with a hemoglobin A1c (HbA1c) of 9.7% (83 mmol/mol) despite using high-dose insulin therapy and metformin.
  2. 02HumanCase report or seriesEfficacy outcome

    In a man with T2DM, daily insulin dosage fell to 20 units, a 94% decrease, after dulaglutide addition.

    In plain wordsIn a man with T2DM, insulin dosage fell after dulaglutide was added to his treatment.

    Peptide
    Dulaglutide (Trulicity)
    Outcome
    DecreaseDaily insulin requirement
    Study

    n = 1

    Comparator
    Before dulaglutide addition
    Outcome group
    Glycemic control · Metabolic and weight
    Studied dose
    Dose not stated · A few monthsAs given in this study (human).

    Measurements

    Daily insulin dosage
    20 units
    after adding dulaglutide
    Daily insulin dosage change
    94%
    after adding dulaglutide

    Source sentences

    Summary
    A few months after adding dulaglutide to his regimen, the patient's HbA1c declined to 6.3% (45 mmol/mol) despite significant reduction in daily insulin dosage to 20 units (94% decrease), which was accompanied by a 20-pound weight loss.
    2 context sentences
    Summary · context
    We present a patient with T2DM who had marked improvement in glycemic control accompanied by weight loss and a decrease in insulin requirement after adding weekly dulaglutide to U500 regular insulin.
    Summary · context
    A 56-year-old man with T2DM, class III obesity (weight 314 pounds, body mass index 46.4 kg/m2), and hyperlipidemia had uncontrolled glycemia with a hemoglobin A1c (HbA1c) of 9.7% (83 mmol/mol) despite using high-dose insulin therapy and metformin.
  3. 03HumanCase report or seriesEfficacy outcome

    In a man with T2DM, dulaglutide addition was accompanied by a 20-pound weight loss.

    In plain wordsIn a man with T2DM, weight fell after dulaglutide was added to his treatment.

    Peptide
    Dulaglutide (Trulicity)
    Outcome
    DecreaseBody weight
    Study

    n = 1

    Comparator
    Before dulaglutide addition
    Outcome group
    Body weight · Metabolic and weight
    Studied dose
    Dose not stated · A few monthsAs given in this study (human).

    Measurements

    Weight loss
    20 pounds
    after adding dulaglutide

    Source sentences

    Summary
    A few months after adding dulaglutide to his regimen, the patient's HbA1c declined to 6.3% (45 mmol/mol) despite significant reduction in daily insulin dosage to 20 units (94% decrease), which was accompanied by a 20-pound weight loss.
    2 context sentences
    Summary · context
    We present a patient with T2DM who had marked improvement in glycemic control accompanied by weight loss and a decrease in insulin requirement after adding weekly dulaglutide to U500 regular insulin.
    Summary · context
    A 56-year-old man with T2DM, class III obesity (weight 314 pounds, body mass index 46.4 kg/m2), and hyperlipidemia had uncontrolled glycemia with a hemoglobin A1c (HbA1c) of 9.7% (83 mmol/mol) despite using high-dose insulin therapy and metformin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    22 Oct 2026, 02:26 UTC

    Study results updated

  2. Version 2

    21 Oct 2026, 18:59 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:05 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.